Targeted Therapy of Acute Myeloid Leukemia, Editor Michael Andreeff

Status

Published

on 12 Dec 2014

Year of Creation

2014

Springer Science+Business Media, LLC

Registration Number

TX0008005311

on 12 Dec 2014

The U.S. Copyright record (Registration Number: TX0008005311) dated 12 Dec 2014, pertains to an electronic file (eService) titled "Targeted Therapy of Acute Myeloid Leukemia, Editor Michael Andreeff" created in 2014. The copyright holder is Springer Science+Business Media, LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media, LLC.

Springer Science+Business Media, LLC

Application Details

Registration Number

TX0008005311

Registration Date

12/12/2014

Year of Creation

2014

Agency Marc Code

DLC-CO

Record Status

Changed

Corporate Author

Springer Science+Business Media, LLC

Physical Description

Book, 826 p

First Publication Nation

United States

ISBN

978-1-4939-1392-3

Corporate Authors

LLC Springer Science+Business Media

Notes

Local Copyright Note: Regarding deposit: work deposited is a collective work

Statements

Application Title Statement: Targeted Therapy of Acute Myeloid Leukemia, Editor Michael Andreeff

Author Statement: Springer Science+Business Media, LLC employer for hire Domicile: not known Citizenship: not known Authorship: text, editing

Notes

Local Copyright Note: Regarding deposit: work deposited is a collective work

Statements

Application Title Statement: Targeted Therapy of Acute Myeloid Leukemia, Editor Michael Andreeff

Author Statement: Springer Science+Business Media, LLC employer for hire Domicile: not known Citizenship: not known Authorship: text, editing

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.